• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆miR-126和miR-143作为脑动脉粥样硬化潜在的新型生物标志物

Plasma miR-126 and miR-143 as Potential Novel Biomarkers for Cerebral Atherosclerosis.

作者信息

Gao Jing, Yang Shuna, Wang Kun, Zhong Qianwei, Ma Aijun, Pan Xudong

机构信息

Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

出版信息

J Stroke Cerebrovasc Dis. 2019 Jan;28(1):38-43. doi: 10.1016/j.jstrokecerebrovasdis.2018.09.008. Epub 2018 Oct 9.

DOI:10.1016/j.jstrokecerebrovasdis.2018.09.008
PMID:30309729
Abstract

Cerebral atherosclerosis is the most important mechanism for ischemic stroke. However, specific plasma biomarkers to assess atherosclerosis susceptibility are still lacking. Circulating miRNAs have been shown to be promising biomarkers for various pathologic conditions. We investigated whether plasma miR-126 and miR-143 could be used as biomarkers for identifying and evaluating cerebral atherosclerosis. Results showed that miR-143 and miR-126 might participate in the process of atherosclerosis and were minimally affected by cerebral infarction. Using Pearson correlation analysis, we showed that miR-126 and miR-143 were correlated with the presence and severity of cerebral atherosclerosis. The ability of miR-126 and miR-143 to differentiate atherosclerosis patients from healthy controls was demonstrated via a receiving operating characteristic curve with high specificity and sensitivity. Our data thus indicate that miR-126 and miR-143 may be potential specific biomarkers for atherosclerosis.

摘要

脑动脉粥样硬化是缺血性中风最重要的机制。然而,目前仍缺乏用于评估动脉粥样硬化易感性的特异性血浆生物标志物。循环中的微小RNA(miRNA)已被证明是各种病理状况下很有前景的生物标志物。我们研究了血浆miR - 126和miR - 143是否可作为识别和评估脑动脉粥样硬化的生物标志物。结果显示,miR - 143和miR - 126可能参与动脉粥样硬化过程,且受脑梗死影响极小。通过Pearson相关性分析,我们发现miR - 126和miR - 143与脑动脉粥样硬化的存在及严重程度相关。通过具有高特异性和敏感性的受试者工作特征曲线,证明了miR - 126和miR - 143区分动脉粥样硬化患者与健康对照的能力。因此,我们的数据表明miR - 126和miR - 143可能是动脉粥样硬化潜在的特异性生物标志物。

相似文献

1
Plasma miR-126 and miR-143 as Potential Novel Biomarkers for Cerebral Atherosclerosis.血浆miR-126和miR-143作为脑动脉粥样硬化潜在的新型生物标志物
J Stroke Cerebrovasc Dis. 2019 Jan;28(1):38-43. doi: 10.1016/j.jstrokecerebrovasdis.2018.09.008. Epub 2018 Oct 9.
2
Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans.循环 miR-30a、miR-126 和 let-7b 作为人类缺血性中风的生物标志物。
BMC Neurol. 2013 Nov 16;13:178. doi: 10.1186/1471-2377-13-178.
3
Plasma MicroRNA-16 Is a Biomarker for Diagnosis, Stratification, and Prognosis of Hyperacute Cerebral Infarction.血浆微小RNA-16是超急性脑梗死诊断、分层及预后的生物标志物。
PLoS One. 2016 Nov 15;11(11):e0166688. doi: 10.1371/journal.pone.0166688. eCollection 2016.
4
Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence.循环miR-212与心血管风险标志物的协同作用可增强对动脉粥样硬化存在情况的评估。
PLoS One. 2017 May 30;12(5):e0177809. doi: 10.1371/journal.pone.0177809. eCollection 2017.
5
Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity.急性缺血性脑卒中患者循环促血管生成和抗血管生成 microRNA 的表达及其与疾病严重程度的关系。
Neurol Sci. 2017 Nov;38(11):2015-2023. doi: 10.1007/s10072-017-3071-x. Epub 2017 Sep 5.
6
Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease.血清微小RNA-21和微小RNA-221作为脑血管疾病的潜在生物标志物。
J Vasc Res. 2013;50(4):346-54. doi: 10.1159/000351767. Epub 2013 Jul 13.
7
Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.循环微RNA作为扩张型心肌病的新型生物标志物
Cardiol J. 2017;24(1):65-73. doi: 10.5603/CJ.a2016.0097. Epub 2016 Oct 17.
8
Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.循环 microRNAs 作为脑小血管病所致血管性痴呆的潜在生物标志物。
Age Ageing. 2017 Sep 1;46(5):861-864. doi: 10.1093/ageing/afx090.
9
Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.登革热感染患者血清微小RNA谱失调及潜在生物标志物
Int J Med Sci. 2016 Feb 18;13(3):195-205. doi: 10.7150/ijms.13996. eCollection 2016.
10
Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.鉴定血浆四种微小RNA组合作为骨肉瘤潜在的非侵入性生物标志物。
PLoS One. 2015 Mar 16;10(3):e0121499. doi: 10.1371/journal.pone.0121499. eCollection 2015.

引用本文的文献

1
Differential Pattern of Circulating MicroRNA Expression in Patients with Intracranial Atherosclerosis.颅内动脉粥样硬化患者循环微小RNA表达的差异模式
Biomedicines. 2025 Feb 19;13(2):514. doi: 10.3390/biomedicines13020514.
2
Unraveling the miRNA Puzzle in Atherosclerosis: Revolutionizing Diagnosis, Prognosis, and Therapeutic Approaches.解析动脉粥样硬化中的 miRNA 之谜:革新诊断、预后和治疗方法。
Curr Atheroscler Rep. 2024 Aug;26(8):395-410. doi: 10.1007/s11883-024-01216-4. Epub 2024 Jun 13.
3
Dysregulation of micro-RNA 143-3p as a Biomarker of Carotid Atherosclerosis and the Associated Immune Reactions During Disease Progression.
微 RNA143-3p 失调作为颈动脉粥样硬化的生物标志物及其在疾病进展过程中的相关免疫反应。
J Cardiovasc Transl Res. 2024 Aug;17(4):768-778. doi: 10.1007/s12265-024-10482-1. Epub 2024 Jan 25.
4
Advances of nanoparticle-mediated diagnostic and theranostic strategies for atherosclerosis.纳米颗粒介导的动脉粥样硬化诊断与治疗策略进展
Front Bioeng Biotechnol. 2023 Nov 9;11:1268428. doi: 10.3389/fbioe.2023.1268428. eCollection 2023.
5
Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis.循环微小RNA与多发性硬化症患者的结构和功能磁共振成像参数相关。
Front Mol Neurosci. 2023 Oct 10;16:1173212. doi: 10.3389/fnmol.2023.1173212. eCollection 2023.
6
microRNAs Associated with Carotid Plaque Development and Vulnerability: The Clinician's Perspective.与颈动脉斑块形成和易损性相关的 microRNAs:临床医生的视角。
Int J Mol Sci. 2022 Dec 9;23(24):15645. doi: 10.3390/ijms232415645.
7
miR-590-3p protects against ischaemia/reperfusion injury in an oxygen-glucose deprivation and reoxygenation cellular model by regulating HMGB1/TLR4/MyD88/NF-κB signalling.miR-590-3p 通过调节 HMGB1/TLR4/MyD88/NF-κB 信号通路来保护缺氧/复氧细胞模型免受缺血/再灌注损伤。
Histol Histopathol. 2023 Aug;38(8):941-951. doi: 10.14670/HH-18-562. Epub 2022 Nov 24.
8
Circular RNA hsa_circ_0003574 as a biomarker for prediction and diagnosis of ischemic stroke caused by intracranial atherosclerotic stenosis.环状RNA hsa_circ_0003574作为颅内动脉粥样硬化性狭窄所致缺血性卒中预测和诊断的生物标志物。
Front Pharmacol. 2022 Sep 26;13:961866. doi: 10.3389/fphar.2022.961866. eCollection 2022.
9
microRNA-223 and microRNA-126 are clinical indicators for predicting the plaque stability in carotid atherosclerosis patients.miRNA-223 和 miRNA-126 是预测颈动脉粥样硬化患者斑块稳定性的临床指标。
J Hum Hypertens. 2023 Sep;37(9):788-795. doi: 10.1038/s41371-022-00760-3. Epub 2022 Oct 3.
10
Circulating miR-130a-3p is elevated in patients with cerebral atherosclerosis and predicts 2-year risk of cerebrovascular events.循环 miR-130a-3p 在脑动脉粥样硬化患者中升高,并预测 2 年内脑血管事件的风险。
BMC Neurol. 2022 Aug 22;22(1):308. doi: 10.1186/s12883-022-02829-5.